China Pharma Holdings Balance Sheet Health
Financial Health criteria checks 3/6
China Pharma Holdings has a total shareholder equity of $7.5M and total debt of $4.5M, which brings its debt-to-equity ratio to 60.6%. Its total assets and total liabilities are $16.5M and $9.0M respectively.
Key information
60.6%
Debt to equity ratio
US$4.52m
Debt
Interest coverage ratio | n/a |
Cash | US$1.42m |
Equity | US$7.45m |
Total liabilities | US$9.01m |
Total assets | US$16.47m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CPHI's short term assets ($6.0M) do not cover its short term liabilities ($6.8M).
Long Term Liabilities: CPHI's short term assets ($6.0M) exceed its long term liabilities ($2.2M).
Debt to Equity History and Analysis
Debt Level: CPHI's net debt to equity ratio (41.5%) is considered high.
Reducing Debt: CPHI's debt to equity ratio has increased from 30.4% to 60.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CPHI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: CPHI has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 48.9% each year.